Targeted brain radiation to improve treatment benefit and limit side effects
Part of Brain & nervous system, Cancer clinical trials.
This study tests a more targeted form of stereotactic (precise) brain radiation for people with brain metastases from large cell cancer. It aims to improve the balance between effectiveness and side effects by carefully focusing where the radiation goes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older.
- You have at least one brain metastasis from large cell cancer that is suitable for targeted radiation.
- Your ability to do daily activities is good (Karnofsky score 70 or higher).
- You can sign a consent form to join the study.
- Your MRI (brain scan) is safe for you to have.
- You do not have certain types of cancer in the brain (small cell lung cancer, germinoma, or lymphoma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests a form of focused radiation given in stages to shrink larger brain metastases. It may help people whose tumors are in the brain but not suited to whole-brain radiation alone, while also checking safety and how well the treatment can be delivered.
This study tests giving a single, precise dose of radiation to a brain metastasis just before surgery, to see if it helps control the tumor better without extra side effects. It’s for people who are already planning surgery for a medium-to-large brain tumor that started from another cancer.
This trial tests a new way of giving focused radiation (SRS) to larger brain tumors (2 to 5 cm). It aims to safely treat these big tumors without whole-brain radiation, which can have more side effects.
This Phase 1 study tests how to safely give focused radiation (SRS) at different doses to people with brain metastases. It aims to find a dose level that works well while limiting side effects.
This Phase 2 study tests a precise, no-head-frame radiation technique to treat brain metastases. It may help by aiming radiation tightly at the tumors while limiting exposure to nearby healthy brain.
This Phase 2 trial tests a type of focused radiation (stereotactic radiosurgery, or SRS) for people with small cell lung cancer that has spread to the brain. It looks at whether this approach can treat brain metastases when the cancer has limited to a certain number of spots.
Hear when a new Brain Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.